AroCell AB (AROC) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.010x

Based on the latest financial reports, AroCell AB (AROC) has a cash flow conversion efficiency ratio of -0.010x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.11 Million ≈ $-119.67K USD) by net assets (Skr108.87 Million ≈ $11.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AroCell AB market cap and net worth for the company's overall valuation and market capitalisation.

AroCell AB - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how AroCell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

AroCell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AroCell AB ranked by their cash flow conversion efficiency. See debt repayment capacity of AroCell AB to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Dolphin Entertainment Inc NASDAQ:DLPN	0.060x
Swissnet AG F:81D	N/A
Onelife Capital Advisors Limited NSE:ONELIFECAP	-0.221x
VitzroSys Co Ltd KQ:054220	0.090x
CNPLUS Co. Ltd. KQ:115530	0.851x
Volex Plc LSE:VLX	0.107x
Star Combo Pharma Ltd AU:S66	0.015x
Mynd.ai, Inc. NYSE MKT:MYND	-0.360x

Annual Cash Flow Conversion Efficiency for AroCell AB (2011–2024)

The table below shows the annual cash flow conversion efficiency of AroCell AB from 2011 to 2024. View AroCell AB stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr121.20 Million ≈ $13.04 Million	Skr-2.36 Million ≈ $-253.76K	-0.019x	+76.30%
2023-12-31	Skr163.65 Million ≈ $17.61 Million	Skr-13.44 Million ≈ $-1.45 Million	-0.082x	-33.52%
2022-12-31	Skr222.69 Million ≈ $23.97 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.061x	+52.59%
2021-12-31	Skr217.45 Million ≈ $23.40 Million	Skr-28.21 Million ≈ $-3.04 Million	-0.130x	+61.39%
2020-12-31	Skr56.26 Million ≈ $6.05 Million	Skr-18.90 Million ≈ $-2.03 Million	-0.336x	-79.44%
2019-12-31	Skr80.41 Million ≈ $8.65 Million	Skr-15.06 Million ≈ $-1.62 Million	-0.187x	+37.79%
2018-12-31	Skr54.51 Million ≈ $5.87 Million	Skr-16.41 Million ≈ $-1.77 Million	-0.301x	+7.78%
2017-12-31	Skr46.68 Million ≈ $5.02 Million	Skr-15.24 Million ≈ $-1.64 Million	-0.326x	-188.96%
2016-12-31	Skr63.46 Million ≈ $6.83 Million	Skr-7.17 Million ≈ $-771.34K	-0.113x	+10.05%
2015-12-31	Skr72.69 Million ≈ $7.82 Million	Skr-9.13 Million ≈ $-982.27K	-0.126x	+76.77%
2011-12-31	Skr4.80 Million ≈ $516.22K	Skr-2.59 Million ≈ $-279.05K	-0.541x	--

About AroCell AB

ST:AROC Sweden Diagnostics & Research

Market Cap

$13.39 Million

Skr124.39 Million SEK

Market Cap Rank

#26396 Global

#547 in Sweden

Share Price

Skr0.54

Change (1 day)

+0.00%

52-Week Range

Skr0.54 - Skr0.54

All Time High

Skr15.05